Navigation Links
Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
Date:2/12/2008

BETHESDA, Md., Feb. 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of a comprehensive review article entitled, "BiTE: A new class of antibodies that recruit T cells" in the journal Drugs of the Future. BiTE(R) antibodies are designed to activate the body's T cells to seek and destroy cancer cells in a tightly controlled manner.

The review article discusses recently published preclinical and clinical data on BiTE antibodies, which are evolving into a new class of antibody-based therapeutics, with several new members in various stages of development. One emphasis is on CD19-specific BiTE antibody MT103 (also known as MEDI-538), which produced complete and partial responses at generally well tolerated and very low doses in late-stage lymphoma patients. Another emphasis is on several preclinical studies showing significant anti-tumor activity of three other BiTE antibodies targeting solid tumors by EpCAM (CD326), EphA2 or CEA antigens. All three tumor-associated antigens are found on many solid tumors. In addition, the article provides a detailed description of the mode of action of BiTE antibodies, comparing it to natural T-cell responses.

"Our latest review article demonstrates the clinical progress and high level of scientific understanding the company has acquired in numerous published studies about its proprietary BiTE antibody technology," commented Patrick A. Baeuerle, Micromet's chief scientific officer. "BiTE antibodies represent a novel platform of clinically-validated, antibody-based therapeutics for the treatment of a wide range of cancers
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
5. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
6. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
7. Inverseon Announces Positive Phase IIa Asthma Study
8. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
9. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
10. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
11. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., WALTHAM,Mass.,Nov.25/PRNewswire/--AccordingtoM...dicaltechnologymarketintelligence,thenearly$3billi...erapidgrowthoverthenextfiveyearsdespitetherecentec...10 reportfindsthatthismarketwillremainhighlydynami...ecializeddevicesinpreviouslyunderservedsegmentsoft...
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,November25...ionandPyxisDiscoveryannouncedtoday,thattheyhavesig...anies,services. , Pyxis,sworldclasscomputatio...dwithiThemba,sservicedivisiontoprovidemedicinaland...ughPyxis,internationalclientnetwork.iThembaPharma...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--En...vasivetreatmentsforaorticdisorders,announcedtodayt...ingsin,thepatentinfringementlawsuitbroughtagainsti...tedStatesDistrictCourtinIndianapolis,Indiana. ,...iletheUnitedStatesPatentandTrademarkOffice(USPTO)c...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Television has less effect on education about climate change than other forms of media 10393 1Television has less effect on education about climate change than other forms of media 10393 2Tylenol May Weaken Effectiveness of Kids Vaccines 59635 1Tylenol May Weaken Effectiveness of Kids Vaccines 59635 2Medifast Inc Named by Forbes as One of Americas 200 Best Small Companies 59631 1Medifast Inc Named by Forbes as One of Americas 200 Best Small Companies 59631 2Medifast Inc Named by Forbes as One of Americas 200 Best Small Companies 59631 3
...ts treated at the initial dose in an ongoing Phase...ad decline after three days , , Conference Call T... Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ann... Phase Ib clinical trial of ANA598, the Company,s ...r. ANA598 was very well-tolerated and demonstrate...
...reterm Infants Drive the Increase , , WHITE PLAIN... that the decades-long rise in the United States p...than ever at increased risk of death and disabilit...,000 babies were born too soon in 2006, according ...h today released "Births: Final data for 2006," Na...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2
(Date:11/26/2009)..., The copper sequestering drug tetrathiomolybdate... the treatment of Wilson disease, a disease caused...cancers. That much is known. Very little, however,...r level. , A new study led by Northwestern Unive...lue: the three-dimensional structure of TM bound t...
(Date:11/26/2009)..., Dr. David Kim of the Li...loss surgery in Dallas , is one of a growing numbe...ar social networking sites to connect with individ...eatment to fight morbid obesity. Dr. Kim is utiliz...information about his practice with the community....
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/...dentist.Butachiropractorcanalsogivepatientsthehelp...hichiswhereyourjaw(mandible)contacts/connectswithy...sassociatedwithTMJdysfunctionarepainwithchewing,cl...ausedfromTMJdysfunctionincluding:headaches,fatigue...
(Date:11/25/2009)...,, TORONTO,Nov.25/PRNewswire/-SentinelleMedi...ancedvisualizationsoftwarelaunchesasuiteofnewleadi...gingsoftwareplatformatthisyear,sRadiologicalSociet...-Dec.5,2009(Booth5800,HallA).Theapplicationslevera...sspecializedMRIimagingcoilsandsupportmultipleimagi...
(Date:11/25/2009)...,, SANFRANCISCO,Nov.25/PRNewswire/--TheBayAr...first Winter Spare the Air Alert for...acturedfirelogsoranyothersolidfuel,bothindoorsando...nhealthyairqualitytomorrow,"saidJackBroadbent,exec...sidentstorespectthehealthoftheirneighborsandfellow...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...inent New York personal injury lawyer reacts to ha...t cites major problems injured workers face when s...tate. , New York, NY (PRW...an face another day of frustration and failure at ...
...nefit from Personalized Attention , , DENVER, Apr...w specialist at Western Orthopaedics, specializes ...rything from a 45-minute technique called shoulder...erican Academy of Orthopaedic Surgeons, there are ...
... which preterm infants are at risk of developing t... A new study from the Sahlgrenska Academy, Univers... weekly weight development might replace the need ...eterm infants are at increased risk of damage to s...
... Children International,s Youth Health Corps ce... the world at record rates! , , To view the Mult....com/mnr/childreninternational/37664/ , , (Photo...pleted training in order to teach their peers abou...
...he art Fujitsu PalmSecure(TM) Biometric Authentica... and patient information updating to revolutionize...ces , , CHICAGO and SUNNYVALE, Calif., April 7 ...cripts Patient Kiosk (TM), the next generation ...
...ting and Siebel Systems involved with new independ... Univita Health, a new company aimed at promoting ...dent aging, today announced the election of George...s joining us on our mission to help people live an...
Other Medicine News:Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 2Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 3Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 4Health News:Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care 2Health News:Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care 3Health News:New, simple method identifies preterm infants at risk of eye disease 2Health News:Photos: Report Shows Youth Health Educators Reach More Poor Teens with a Message of Living Healthy Lives! 2Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 2Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 3Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 4Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 5Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 6Health News:Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk 7Health News:George T. Shaheen Joins Board of Directors at Univita Health 2
...icroplate processor designed to completely automat... dedicated to smooth and safe handling of material...m architecture allows laboratories easy selection ...croplate based requirements. Evolis is a state-of...
Variant II Total GHb Program
... has revolutionized the treatment of the upper ext...onstruct was used in the developmemt of the tibia ...blood supply and soft tissue coverage, presents sp...d, tapered, non-reamed True/Flex,Tibia Nail is i...
...n provide to your patients, Davol offers a complet...s, standardization and reimbursement guidelines, a...age systems deliver the performance needed for qui..., and foreign material. Each provides controlled p...
Medicine Products: